Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-20 | Dr. Laurent M. HumeauChief Scientific Officer & Chairman of the Scientific Advisory Board | 3,86k | 0,00 | Derivative Exercise and Retained Stock | - | 46,82k | 8,99% |
| 2026-05-20 | Dr. Laurent M. HumeauChief Scientific Officer & Chairman of the Scientific Advisory Board | -2,16k | 2,66k | Derivative Exercise and Sale | 1,23 | 46,82k | - |
| 2026-05-20 | Dr. Michael SumnerChief Medical Officer & Head of Development | -2,69k | 3,31k | Derivative Exercise and Sale | 1,23 | 42,04k | - |
| 2026-05-20 | Dr. Michael SumnerChief Medical Officer & Head of Development | 6,76k | 0,00 | Derivative Exercise and Retained Stock | - | 42,04k | 19,15% |
| 2026-05-20 | Mr. Peter D. KiesCFO | 4,01k | 0,00 | Derivative Exercise and Retained Stock | - | 43,23k | 10,23% |
| 2026-05-20 | Mr. Peter D. KiesCFO | -4,69k | 5,77k | Derivative Exercise and Sale | 1,23 | 43,23k | - |
| 2026-05-20 | Dr. Jacqueline E. SheaCEO, President & Director | 15,99k | 0,00 | Derivative Exercise and Retained Stock | - | 111,02k | 16,83% |
| 2026-05-20 | Dr. Jacqueline E. SheaCEO, President & Director | -12,31k | 15,14k | Derivative Exercise and Sale | 1,23 | 111,02k | - |
| 2026-05-15 | Mr. Peter D. KiesCFO | 2,20k | 0,00 | Derivative Exercise and Retained Stock | - | 39,22k | 5,94% |
| 2026-05-15 | Mr. Peter D. KiesCFO | -2,57k | 3,34k | Derivative Exercise and Sale | 1,30 | 39,22k | - |
| 2026-05-15 | Dr. Jacqueline E. SheaCEO, President & Director | 10,03k | 0,00 | Derivative Exercise and Retained Stock | - | 95,03k | 11,80% |
| 2026-05-15 | Dr. Jacqueline E. SheaCEO, President & Director | -7,72k | 10,03k | Derivative Exercise and Sale | 1,30 | 95,03k | - |
| 2026-05-15 | Dr. Laurent M. HumeauChief Scientific Officer & Chairman of the Scientific Advisory Board | 3,06k | 0,00 | Derivative Exercise and Retained Stock | - | 42,96k | 7,67% |
| 2026-05-15 | Dr. Laurent M. HumeauChief Scientific Officer & Chairman of the Scientific Advisory Board | -1,71k | 2,23k | Derivative Exercise and Sale | 1,30 | 42,96k | - |
| 2026-05-15 | Dr. Michael SumnerChief Medical Officer & Head of Development | 1,71k | 0,00 | Derivative Exercise and Retained Stock | - | 35,28k | 5,08% |
| 2026-05-15 | Dr. Michael SumnerChief Medical Officer & Head of Development | -680,00 | 884,00 | Derivative Exercise and Sale | 1,30 | 35,28k | - |
| 2026-03-31 | Dr. Michael SumnerChief Medical Officer & Head of Development | 3,07k | 0,00 | Derivative Exercise and Retained Stock | - | 33,58k | 10,06% |
| 2026-03-31 | Dr. Michael SumnerChief Medical Officer & Head of Development | -1,22k | 2,13k | Derivative Exercise and Sale | 1,74 | 33,58k | - |
| 2026-02-26 | Dr. Laurent M. HumeauChief Scientific Officer & Chairman of the Scientific Advisory Board | 7,28k | 0,00 | Derivative Exercise and Retained Stock | - | 39,90k | 22,31% |
| 2026-02-26 | Dr. Laurent M. HumeauChief Scientific Officer & Chairman of the Scientific Advisory Board | -5,10k | 9,13k | Derivative Exercise and Sale | 1,79 | 39,90k | - |
| 2026-02-26 | Mr. Peter D. KiesCFO | 6,39k | 0,00 | Derivative Exercise and Retained Stock | - | 37,02k | 20,84% |
| 2026-02-26 | Mr. Peter D. KiesCFO | -9,26k | 16,57k | Derivative Exercise and Sale | 1,79 | 37,02k | - |
| 2026-02-26 | Dr. Jacqueline E. SheaCEO, President & Director | 25,32k | 0,00 | Derivative Exercise and Retained Stock | - | 85,00k | 42,42% |
| 2026-02-26 | Dr. Jacqueline E. SheaCEO, President & Director | -21,71k | 38,87k | Derivative Exercise and Sale | 1,79 | 85,00k | - |
| 2026-02-26 | Dr. Michael SumnerChief Medical Officer & Head of Development | 12,66k | 0,00 | Derivative Exercise and Retained Stock | - | 30,51k | 70,91% |
| 2026-02-26 | Dr. Michael SumnerChief Medical Officer & Head of Development | -3,90k | 6,99k | Derivative Exercise and Sale | 1,79 | 30,51k | - |
| 2026-02-26 | Dr. David B. WeinerMember of the Scientific Advisory Board & Director | 972,00 | 0,00 | Derivative Exercise and Retained Stock | - | 87,59k | 1,12% |
| 2025-06-30 | Dr. Michael SumnerChief Medical Officer & Head of Development | 2,92k | 0,00 | Derivative Exercise and Retained Stock | - | 17,85k | 19,53% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
